BioPharma Technology Development LLP (BTD)
BioPharma Technology Development fosters the commercial
development of pharmaceutical and biotechnology products.
BTD provides services that range from evaluating the
potential and the development pathways for novel
technologies (either for investors or holders of
intellectual property) to creating start-up organizations as
a vehicle to commercialize specific opportunities. BTD is
managed by the two founding partners, Dr. Kenneth W. Narducy
and Dr., J. Michael Delmage, who combined have more than a
half century of successful pharmaceutical and biotechnology
development experience.
